Vicore Pharma Holding AB (VCRE) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $8.98, -1.21% vs the prior close of $9.09.
- Volume 3.24K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VCRE dips 1.2% to $8.98. Closed at $8.98, -1.21% vs the prior close of $9.09. Day range $8.76–$8.98, opened at $8.76.
VCRE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — VCRE dips 1.2% to $8.98
- Closed at $8.98, -1.21% vs the prior close of $9.09. Day range $8.76–$8.98, opened at $8.76.
- Volume was 3.24K shares, 0.1x its 50-day average of 21.90K — lighter than usual.
- Price is -15.9% vs its 50-day average ($10.68).
- 52-week range $7.88–$17.80; today's close sits at 11% of that range, 49.6% below the 52-week high.
Oct 15, 2026 — VCRE ends flat (+0.1%) to $9.09 on 1.8x normal volume
- Closed at $9.09, +0.11% vs the prior close of $9.08. Day range $8.93–$9.49, opened at $9.00.
- Volume was 38.50K shares, 1.8x its 50-day average of 21.14K — unusually heavy trading.
- Price is -15.3% vs its 50-day average ($10.74).
- 52-week range $7.88–$17.80; today's close sits at 12% of that range, 48.9% below the 52-week high.
Oct 14, 2026 — VCRE rises 1.5% to $9.08
- Closed at $9.08, +1.45% vs the prior close of $8.95. Day range $8.95–$9.64, opened at $9.00.
- Volume was 23.10K shares, 1.1x its 50-day average of 20.96K.
- Price is -15.9% vs its 50-day average ($10.79).
- 52-week range $7.88–$17.80; today's close sits at 12% of that range, 49.0% below the 52-week high.
Oct 13, 2026 — VCRE slides 3.0% to $8.95
- Closed at $8.95, -3.03% vs the prior close of $9.23. Day range $8.89–$9.25, opened at $9.10.
- Volume was 27.80K shares, 1.4x its 50-day average of 20.51K.
- Price is -17.5% vs its 50-day average ($10.85).
- 52-week range $7.88–$17.80; today's close sits at 11% of that range, 49.7% below the 52-week high.
Oct 12, 2026 — VCRE rises 2.6% to $9.23 on 2.2x normal volume
- Closed at $9.23, +2.56% vs the prior close of $9.00. Day range $8.95–$9.59, opened at $9.06.
- Volume was 43.50K shares, 2.2x its 50-day average of 19.67K — unusually heavy trading.
- Price is -15.3% vs its 50-day average ($10.90).
- 52-week range $7.88–$17.80; today's close sits at 14% of that range, 48.1% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — VCRE rises 2.0% to $9.00
- Closed at $9.00, +2.04% vs the prior close of $8.82. Day range $8.85–$9.30, opened at $9.01.
- Volume was 31.00K shares, 1.6x its 50-day average of 19.08K.
- Price is -17.8% vs its 50-day average ($10.95).
- 52-week range $7.88–$17.80; today's close sits at 11% of that range, 49.4% below the 52-week high.
Oct 8, 2026 — VCRE rises 1.8% to $8.82
- Closed at $8.82, +1.85% vs the prior close of $8.66. Day range $8.20–$8.96, opened at $8.78.
- Volume was 21.10K shares, 1.1x its 50-day average of 18.68K.
- Price is -19.8% vs its 50-day average ($10.99).
- 52-week range $7.88–$17.80; today's close sits at 9% of that range, 50.4% below the 52-week high.
Oct 7, 2026 — VCRE dips 0.9% to $8.66, a 3-month low, 9 down days in a row
- Closed at $8.66, -0.92% vs the prior close of $8.74. Day range $7.88–$8.96, opened at $8.68.
- Volume was 32.00K shares, 1.8x its 50-day average of 18.08K.
- Price is -21.5% vs its 50-day average ($11.04).
- 52-week range $7.88–$17.80; today's close sits at 8% of that range, 51.3% below the 52-week high.
- That makes 9 straight losses.
Oct 6, 2026 — VCRE dips 2.9% to $8.74, a 3-month low, 8 down days in a row
- Closed at $8.74, -2.89% vs the prior close of $9.00. Day range $8.69–$9.47, opened at $9.18.
- Volume was 22.80K shares, 1.3x its 50-day average of 17.65K.
- Price is -21.2% vs its 50-day average ($11.09).
- 52-week range $8.69–$17.80; today's close sits at 1% of that range, 50.9% below the 52-week high.
- That makes 8 straight losses.
Oct 5, 2026 — VCRE slides 3.5% to $9.00, a 3-month low, 7 down days in a row
- Closed at $9.00, -3.54% vs the prior close of $9.33. Day range $8.94–$9.80, opened at $9.25.
- Volume was 11.80K shares, 0.7x its 50-day average of 17.45K.
- Price is -19.2% vs its 50-day average ($11.14).
- 52-week range $8.79–$17.80; today's close sits at 2% of that range, 49.4% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 — VCRE dips 1.1% to $9.33, a 3-month low, 6 down days in a row
- Closed at $9.33, -1.06% vs the prior close of $9.43. Day range $8.99–$9.57, opened at $9.45.
- Volume was 27.50K shares, 1.6x its 50-day average of 16.98K.
- Price is -16.6% vs its 50-day average ($11.18).
- 52-week range $8.79–$17.80; today's close sits at 6% of that range, 47.6% below the 52-week high.
- That makes 6 straight losses.
VCRE latest news & SEC filings
Every SEC filing by or about VCRE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 21, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 30, 2026 · Form SEC STAFF ACTION — SEC STAFF ACTION filing
SEC STAFF ACTION filing
Things to know before you trade VCRE
- How much it moves: over the last 20 sessions the average daily move was 1.60% (largest 3.5%).
- Liquidity: about 34.99K shares (≈$314.23K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $8.98 vs a range of $7.88–$17.80 (11% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 30, 2026; 6-K Aug 21, 2026; 6-K Jul 6, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
VCRE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.76 | 8.98 | 8.76 | 8.98 | 3.24K |
| Oct 15, 2026 | 9.00 | 9.49 | 8.93 | 9.09 | 38.50K |
| Oct 14, 2026 | 9.00 | 9.64 | 8.95 | 9.08 | 23.10K |
| Oct 13, 2026 | 9.10 | 9.25 | 8.89 | 8.95 | 27.80K |
| Oct 12, 2026 | 9.06 | 9.59 | 8.95 | 9.23 | 43.50K |
| Oct 9, 2026 | 9.01 | 9.30 | 8.85 | 9.00 | 31.00K |
| Oct 8, 2026 | 8.78 | 8.96 | 8.20 | 8.82 | 21.10K |
| Oct 7, 2026 | 8.68 | 8.96 | 7.88 | 8.66 | 32.00K |
| Oct 6, 2026 | 9.18 | 9.47 | 8.69 | 8.74 | 22.80K |
| Oct 5, 2026 | 9.25 | 9.80 | 8.94 | 9.00 | 11.80K |
| Oct 2, 2026 | 9.45 | 9.57 | 8.99 | 9.33 | 27.50K |
| Oct 1, 2026 | 9.60 | 10.01 | 9.19 | 9.43 | 41.10K |
| Sep 30, 2026 | 9.51 | 10.05 | 8.99 | 9.51 | 20.40K |
| Sep 29, 2026 | 9.60 | 10.11 | 9.31 | 9.52 | 65.50K |
| Sep 28, 2026 | 9.59 | 9.71 | 8.79 | 9.59 | 27.50K |
| Sep 25, 2026 | 9.67 | 9.84 | 9.60 | 9.65 | 6.70K |
| Sep 24, 2026 | 9.73 | 9.91 | 9.50 | 9.91 | 21.10K |
| Sep 23, 2026 | 10.23 | 10.23 | 9.64 | 9.80 | 101.70K |
| Sep 22, 2026 | 10.26 | 10.52 | 10.11 | 10.16 | 19.70K |
| Sep 21, 2026 | 10.40 | 11.14 | 10.10 | 10.20 | 113.80K |
About Vicore Pharma Holding AB
Vicore Pharma Holding AB (VCRE) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in STOCKHOLM. State of incorporation: Sweden. Fiscal year ends December 31. SEC CIK 2124403.
VCRE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
VCRE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
VCRE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on VCRE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.